Search

Your search keyword '"Julie D. Atkin"' showing total 65 results

Search Constraints

Start Over You searched for: Author "Julie D. Atkin" Remove constraint Author: "Julie D. Atkin" Topic biology Remove constraint Topic: biology
65 results on '"Julie D. Atkin"'

Search Results

1. The Mitochondrial-associated ER membrane (MAM) compartment and its dysregulation in Amyotrophic Lateral Sclerosis (ALS)

2. Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations

3. CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis

4. Protein disulphide isomerase (PDI) is protective against several types of DNA damage, including that induced by amyotrophic lateral sclerosis-associated mutant TDP-43 in neuronal cells/ in vitro models

5. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins

6. Is cytoplasmic FUS a feature of all ALS?

7. Motor Neuron Abnormalities Correlate with Impaired Movement in Zebrafish that Express Mutant Superoxide Dismutase 1

8. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis

9. Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy

10. The Cysteine (Cys) Residues Cys-6 and Cys-111 in Mutant Superoxide Dismutase 1 (SOD1) A4V Are Required for Induction of Endoplasmic Reticulum Stress in Amyotrophic Lateral Sclerosis

11. Motor Neuron Susceptibility in ALS/FTD

12. Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress

13. Rab-dependent cellular trafficking and amyotrophic lateral sclerosis

14. Protein Disulphide Isomerases: emerging roles of PDI and ERp57 in the nervous system and as therapeutic targets for ALS

15. Protein folding alterations in amyotrophic lateral sclerosis

16. NFκB is a central regulator of protein quality control in response to protein aggregation stresses via autophagy modulation

17. The Redox Activity of Protein Disulfide Isomerase Inhibits ALS Phenotypes in Cellular and Zebrafish Models

18. Protein disulphide isomerase is associated with mutant SOD1 in canine degenerative myelopathy

19. The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis

20. Rab1-dependent ER–Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS

21. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

22. Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF(cyclin F) complex

23. Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis

24. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1

25. Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum

26. SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis

27. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis

28. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking

29. The Role of S-Nitrosylation and S-Glutathionylation of Protein Disulphide Isomerase in Protein Misfolding and Neurodegeneration

30. N-linked glycosylation modulates dimerization of protein disulfide isomerase family A member 2 (PDIA2)

31. A novel amyotrophic lateral sclerosis mutation in OPTN induces ER stress and Golgi fragmentation in vitro

32. Erratum

33. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

34. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis

35. Efficacy of peptide nucleic acid and selected conjugates against specific cellular pathologies of amyotrophic lateral sclerosis

36. Molecular Motor Proteins and Amyotrophic Lateral Sclerosis

37. Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice

38. Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis

39. RETRACTED: Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis

40. Autophagy dysregulation by mutant fused in sarcoma--implications for amyotrophic lateral sclerosis

41. ALS-associated mutant FUS inhibits macroautophagy which is restored by overexpression of Rab1

42. Novel roles for protein disulphide isomerase in disease states: a double edged sword?

43. ER Stress and UPR in Familial Amyotrophic Lateral Sclerosis

44. Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis

45. Motor neuron disease proteins activate complement and generate C5a

46. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43

47. Dysregulation of the complement cascade in the hSOD1G93Atransgenic mouse model of amyotrophic lateral sclerosis

48. Mutant SOD1 inhibits ER-Golgi transport in amyotrophic lateral sclerosis

49. Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells

50. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation

Catalog

Books, media, physical & digital resources